Facial Tissue

Applicable Standard: Regulated under KEBS quality requirements for tissue and hygiene paper products (softness, absorbency, and wet-strength additive safety verified against the ISO 12625 tissue-paper test series).

Facial tissue looks like a simpler cousin of toilet paper, but it actually carries a more complex compliance profile in two specific respects: it is engineered with wet-strength resins to hold together when damp with mucus or moisture, and an increasing share of the market is sold as “lotion” or “aloe vera” facial tissue with an additive layer applied directly to the sheet. Both of those design choices introduce chemical-safety questions that plain toilet tissue doesn’t have to answer, since the product is used directly against the face — often around the eyes and nose — rather than for general-purpose cleaning. Importers who source facial tissue purely on softness and box design, without asking what wet-strength chemistry or lotion formulation is actually in the sheet, are the ones most exposed when a shipment gets a closer look. The category also sees disproportionate private-label activity — supermarket and pharmacy own-brand facial tissue — which raises the stakes further, since a retailer’s brand name ends up carrying the compliance risk of a formulation it never independently verified. Box construction adds a second, often overlooked layer to the assessment as well — the cardboard carton itself, and any plastic film dispensing window, is a secondary packaging component with its own basic quality expectations around structural integrity and, where a window is used, food-and-consumer-contact material safety.

Why This Category Gets Flagged

The most common issue is sheet count and grammage falling short of what’s printed on the box — a box declaring “100 2-ply tissues” that measures out lighter or fewer once independently checked, which is a straightforward quantity-and-weight compliance failure rather than a safety one, but a compliance failure all the same. The second is wet-strength resin residue: the formaldehyde-based bonding agents historically used to give facial tissue its damp-use durability are subject to residue limits, and manufacturers who haven’t updated their formulation in years are the ones most likely to be carrying legacy chemistry that no longer clears a modern residue screen. The third, specific to the lotion-infused segment, is an undisclosed or unscreened fragrance and preservative system in the lotion layer — a product used repeatedly against facial skin and around the eyes with no allergen or dermatological safety data behind its additive is exactly the kind of gap a compliance review targets first. A fourth issue that surfaces regularly in private-label sourcing is a supplier switch mid-contract — a retailer approves one factory’s formulation, then the actual production run ships from a different, unaudited facility with a different lotion or bonding-resin recipe that was never independently tested against the original approval.

Test Parameters

A facial tissue compliance assessment typically verifies the following parameters:

Labeling Requirements

The box or pack must declare sheet count, ply, batch or lot number, manufacture date, and — where the product is lotion-infused — a full ingredient or additive declaration for the applied lotion layer, since this is a leave-on-skin formulation in miniature and treated with the corresponding scrutiny. Storage guidance (protect from moisture) is expected given the product’s absorbency, and country of origin and manufacturer contact information must be legible on the retail unit. Any “extra soft,” “hypoallergenic,” or “gentle on skin” claim should be backed by test data on file, since these are the claims most likely to be checked in a market-surveillance sample specifically because they speak directly to facial and nasal skin comfort. For private-label facial tissue specifically, the label’s country-of-origin and manufacturer declaration should match the facility that actually produced the shipped batch, not the facility named in an earlier supplier approval.

Packaging & Documentation

A compliant facial tissue shipment should be supported by:

Typical Gaps We Find

Sheet-count shortfall is the single most common defect we find in this category — boxes that measure a handful of sheets short of the declared count, which sounds trivial per box but compounds into a real consumer-protection issue across a full production run. The second most common gap is lotion-infused facial tissue shipped with zero allergen or dermatological documentation behind the additive layer, even though it’s a formulation applied directly to skin around the eyes and nose repeatedly over a box’s lifespan. Wet-strength resin residue testing is the gap importers are least likely to have even considered, since it requires understanding the specific bonding chemistry used in the sheet rather than just its finished feel — which is exactly why it’s worth confirming before a shipment leaves origin rather than after. Private-label supplier substitution is the fourth pattern we watch for — a formulation approved once at the start of a retail contract, with no ongoing verification that later production runs still match what was originally tested and approved. Box and dispenser-window integrity issues round out the picture — a secondary packaging defect that doesn’t affect the tissue itself but still reflects on overall shipment quality and, for windowed cartons, occasionally raises its own consumer-contact material question that’s easy to overlook next to the tissue formulation questions that dominate a typical review.